Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
C. Andrew DeRyke, PharmD
IHMA
Disclosure(s): No financial relationships to disclose
Poster(s):
(P-1518) Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam and Comparators Against Clinical MDR and DTR non-
Morganellaceae
Enterobacterales and
Pseudomonas aeruginosa
Stratified by Patient Age and Hospital Ward: SMART United States 2020-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1519) Susceptibility of Clinical Non-
Morganellaceae
Enterobacterales Isolates from Bloodstream and Respiratory Tract Infections to Imipenem/Relebactam and Comparators: SMART United States 2020-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1520) Addition of Relebactam Increases Susceptibility to Imipenem Among Imipenem-Intermediate
Pseudomonas aeruginosa
: Asia/Pacific SMART 2018-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
